Literature DB >> 24075646

Transition from an autoimmune-prone state to fatal autoimmune disease in CCR7 and RORγt double-deficient mice is dependent on gut microbiota.

Katharina Wichner1, André Fischer, Susann Winter, Solveig Tetzlaff, Markus M Heimesaat, Stefan Bereswill, Armin Rehm, Martin Lipp, Uta E Höpken.   

Abstract

Autoimmunity is associated with a strong genetic component, but onset and persistence of clinically apparent autoimmune diseases often require an additional environmental trigger. The balance between immunity and tolerance is regulated by numerous molecular factors including nuclear hormone and homeostatic chemokine receptors. The nuclear hormone receptor RORγt and the chemokine receptor CCR7 are both essentially involved in functional lymphoid organogenesis and maintenance of lymphocyte homeostasis. Lack of one or the other impairs thymic T cell development and alters T cell homeostasis. Mice deficient for both, Ccr7(-/-)Rorγt(-/-), succumbed early to acute destructive inflammation, characterized by massive recruitment of inflammatory leukocytes, pro-inflammatory cytokine and autoantibody production, and wasting disease. Antibiotic-treatment of mice before disease onset reduced the overall gut microflora and abrogated the development of fatal mucosal inflammation. Hence, commensal bacteria and a confined tissue-specific inflammatory milieu serve as complementary trigger to initiate the lethal pathophysiologic process in Ccr7(-/-)Rorγt(-/-) mice.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CCR7/RORγt double-deficient; DKO; Gut microbiota; Homeostatic chemokine receptor; ILFs; LTis; Mucosal inflammation; Retinoic acid receptor-related orphan receptor; SLO; Thymic T cell development; Tregs; isolated lymphoid follicles; lymphoid tissue inducer cells; regulatory T cells; secondary lymphoid organ

Mesh:

Substances:

Year:  2013        PMID: 24075646     DOI: 10.1016/j.jaut.2013.08.007

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  7 in total

1.  The challenge of treating orphan disease.

Authors:  Carlos Dias; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

2.  Suppression of Peripheral Pain by Blockade of Voltage-Gated Calcium 2.2 Channels in Nociceptors Induces RANKL and Impairs Recovery From Inflammatory Arthritis in a Mouse Model.

Authors:  Uta Baddack; Silke Frahm; Beatriz Antolin-Fontes; Jenny Grobe; Martin Lipp; Gerd Müller; Ines Ibañez-Tallon
Journal:  Arthritis Rheumatol       Date:  2015-06       Impact factor: 10.995

Review 3.  Autoimmunity in 2013.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

4.  Unique topics and issues in rheumatology and clinical immunology.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

5.  Extrahepatic malignancies in primary biliary cirrhosis: a comparative study at two European centers.

Authors:  Annarosa Floreani; Alice Spinazzè; Llorenc Caballeria; Ana Reig; Nora Cazzagon; Irene Franceschet; Alessandra Buja; Patrizia Furlan; Kenichi Harada; Patrick Sc Leung; M Eric Gershwin; Albert Pares
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

6.  iNKT cells prevent obesity-induced hepatic steatosis in mice in a C-C chemokine receptor 7-dependent manner.

Authors:  H M Kim; B R Lee; E S Lee; M H Kwon; J H Huh; B-E Kwon; E-K Park; S-Y Chang; M-N Kweon; P-H Kim; H-J Ko; C H Chung
Journal:  Int J Obes (Lond)       Date:  2017-08-16       Impact factor: 5.095

7.  Triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia.

Authors:  Céline Pomié; Vincent Blasco-Baque; Pascale Klopp; Simon Nicolas; Aurélie Waget; Pascale Loubières; Vincent Azalbert; Anthony Puel; Frédéric Lopez; Cédric Dray; Philippe Valet; Benjamin Lelouvier; Florence Servant; Michael Courtney; Jacques Amar; Rémy Burcelin; Lucile Garidou
Journal:  Mol Metab       Date:  2016-03-28       Impact factor: 7.422

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.